Mild parkinsonian signs and plasma homocysteine concentration in community-dwelling elderly individuals

Archives of Neurology

Volumn 64, Issue 11, 2007, Pages 1646-1651

  Louis, Elan D ^a,b,c,d   Schupf, Nicole ^a,b,c   Tang, Ming X ^a,b,c   Marder, Karen ^a,b   Luchsinger, Jose A ^b  

^a Taub Institute for Research on Alzheimer's Disease and the Aging Brain and the Gertrude H Sergievsky Center   (United States)

^b Neurological Institute ^*  (United States)

^c NONE   (United States)

^d NEUROLOGICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HOMOCYSTEINE; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; COMMUNITY LIVING; CONTROLLED STUDY; DISEASE SEVERITY; ELDERLY CARE; FEMALE; HUMAN; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PARKINSONISM; PRIORITY JOURNAL; SCORING SYSTEM; SEX RATIO; UNIFIED PARKINSON DISEASE RATING SCALE; UNITED STATES;

AGED; AGED, 80 AND OVER; COHORT STUDIES; COMMUNITY HEALTH PLANNING; CROSS-SECTIONAL STUDIES; DEMENTIA; FEMALE; GERIATRIC ASSESSMENT; HOMOCYSTEINE; HUMANS; MALE; MASS SPECTROMETRY; NEUROLOGIC EXAMINATION; NEUROPSYCHOLOGICAL TESTS; PARKINSONIAN DISORDERS; RESIDENCE CHARACTERISTICS;

EID: 36148993290     PISSN: 00039942     EISSN: 15383687     Source Type: Journal    
DOI: 10.1001/archneur.64.11.1646     Document Type: Article

References (33)

1. Louis ED, Luchsinger JA, Tang M-X, Mayeux R. Parkinsonian signs in older people: prevalence and associations with smoking and coffee consumption. Neurology. 2003;61(1):24-28.
2. Bennett DA, Beckett LA, Murray AM, et al. Prevalence of parkinsonian signs and associated mortality in a community population of older people. N Engl J Med. 1996;334(2):71-76.
3. Richards M, Stern Y, Mayeux R. Subtle extrapyramidal signs can predict the development of dementia in elderly individuals. Neurology. 1993;43(11):2184-2188.
4. Bennett DA, Shannon KM, Beckett LA, Goetz CG, Wilson RS. Metric properties of nurses' ratings of parkinsonian signs with a modified Unified Parkinson's Disease Rating Scale. Neurology. 1997;49(6):1580-1587.
5. Wilson RS, Schneider JA, Bienias JL, Evans DA, Bennett DA. Parkinsonian-like signs and risk of incident Alzheimer's disease in older persons. Arch Neurol. 2003;60(4):539-544.
6. Louis ED, Tang M, Mayeux R. Factor structure of Parkinsonian signs in the community-dwelling elderly. Mov Disord. 2004;19(3):268-272.
7. Louis ED, Tang M-X, Mayeux R. Parkinsonian signs in older people in a community-based study: risk of incident dementia. Arch Neurol. 2004;61(8):1273-1276.
8. Louis ED, Tang MX, Schupf N, Mayeux R. Functional correlates and prevalence of mild parkinsonian signs in a community population of older people. Arch Neurol. 2005;62(2):297-302.
9. Fleischman DA, Wilson RS, Schneider JA, Bienias JL, Bennett DA. Parkinsonian signs and functional disability in old age. Exp Aging Res. 2007;33(1):59-76.
10. Mitchell SL, Rockwood K. The association between parkinsonism, Alzheimer's disease, and mortality: a comprehensive approach. J Am Geriatr Soc. 2000;48(4):422-425.
11. Todorović Z, Dzoljic E, Novakovic I, et al. Homocysteine serum levels and MTHFR C677T genotype in patients with Parkinson's disease, with and without levodopa therapy. J Neurol Sci. 2006;248(1-2):56-61.
12. Soumaré A, Elbaz A, Ducros V, Tavernier B, Alpérovitch A, Tzourio C. Cross-sectional association between homocysteine and motor function in the elderly. Neurology. 2006;67(6):985-990.
13. Tang MX, Stern Y, Marder K, et al. The ApoE-ε4 allele and the risk of Alzheimer's disease among African-Americans, whites, and Hispanics. JAMA. 1998;279(10):751-755.
14. Stern MB. The clinical characteristics of Parkinson's disease and parkinsonian syndromes: diagnosis and assessment. In: Stern MB, Hurtig HI, eds. The Comprehensive Management of Parkinson's Disease. New York, NY: PMA Publishing Corp; 1978:34-39.
15. de Rijk MC, Rocca WA, Anderson DW, Melcon MO, Breteler MM, Maraganore DM. A population perspective on diagnostic criteria for Parkinson's disease. Neurology. 1997;48(5):1277-1281.
16. Mayeux R, Marder K, Cote L, et al. The frequency of idiopathic Parkinson's disease by age, ethnic group, and sex in northern Manhattan, 1988-1993. Am J Epidemiol. 1995;142(8):820-827.
17. Stern Y, Andrews H, Pittman J, et al. Diagnosis of dementia in a heterogeneous population: development of a neuropsychological paradigm-based diagnosis of dementia and quantified correction for the effects of education. Arch Neurol. 1992;49(5):453-460.
18. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 3rd ed, revised. Washington, DC: American Psychiatric Association; 1987.
19. Marder K, Tang M-X, Cote L, Stern Y, Mayeux R. The frequency and associated risk factors for dementia in patients with Parkinson's disease. Arch Neurol. 1995;52(7):695-701.
20. Luchsinger JA, Tang M-X, Shea A, Miller J, Green R, Mayeux R. Plasma homocysteine levels and risk of Alzheimer disease. Neurology. 2004;62(11):1972-1976.
21. Richards M, Marder K, Cote L, Mayeux R. Interrater reliability and factor structure of the Unified Parkinson's Disease Rating Scale Motor Examination. Mov Disord. 1994;9(1):89-91.
22. Bureau of the Census. 1990 Census of Population and Housing: Summary Tape File 1, Technical Documentation. STF 1A Database [computer diskette]. Washington, DC: Bureau of the Census, US Depart of Commerce; 1991.
23. Gilfix BM, Blank DW, Rosenblatt DS. Novel reductant for determination of total plasma homocysteine. Clin Chem. 1997;43(4):687-688.
24. van Zagten M, Lodder J, Kessels F. Gait disorder and parkinsonian signs in patients with stroke related to small deep infarcts and white matter lesions. Mov Disord. 1998;13(1):89-95.
25. Sohn YH, Kim J-S. The influence of white matter hyperintensities on the clinical features of Parkinson's disease. Yonsei Med J. 1998;39(1):50-55.
26. Chang CM, Yu YL, Ng HK, Leung SY, Fong KY. Vascular pseudoparkinsonism. Acta Neurol Scand. 1992;86(6):588-592.
27. Tolosa ES, Santamaria J. Parkinsonism and basal ganglia infarcts. Neurology. 1984;34(11):1516-1518.
28. Jellinger K. Overview of morphological changes in Parkinson's disease. Adv Neurol. 1987;45:1-18.
29. Geroldi C, Ferrucci L, Bandinelli S, et al. Mild cognitive deterioration with subcortical features: prevalence, clinical characteristics, and association with cardiovascular risk factors in community-dwelling older persons (the InCHIANTI Study) J Am Geriatr Soc. 2003;51(8):1064-1071.
30. Arvanitakis Z, Wilson RS, Schneider JA, Bienias JL, Evans DA, Bennett DA. Diabetes mellitus and progression of rigidity and gait disturbance in older persons. Neurology. 2004;63(6):996-1001.
31. Louis ED, Luchsinger JA. History of vascular disease and mild Parkinsonian signs in the community-dwelling elderly. Arch Neurol. 2006;63(5):717-722.
32. Kado DM, Bucur A, Selhub J, Rowe JW, Seeman T. Homocysteine levels and decline in physical function: MacArthur Studies of Successful Aging. Am J Med. 2002;113(7):537-542.
33. Toole JF, Malinow MR, Chambless LE, et al. Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) Randomized Controlled Trial. JAMA. 2004;291(5):565-575.